TECH vs. A, MTD, WAT, ILMN, CRL, BIO, BRKR, PACB, HBIO, and TMO
Should you be buying Bio-Techne stock or one of its competitors? The main competitors of Bio-Techne include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry.
Bio-Techne vs.
Agilent Technologies (NYSE:A) and Bio-Techne (NASDAQ:TECH) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability, community ranking, institutional ownership and media sentiment.
Agilent Technologies has higher revenue and earnings than Bio-Techne. Agilent Technologies is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks.
Agilent Technologies received 467 more outperform votes than Bio-Techne when rated by MarketBeat users. Likewise, 71.08% of users gave Agilent Technologies an outperform vote while only 62.38% of users gave Bio-Techne an outperform vote.
98.9% of Bio-Techne shares are owned by institutional investors. 3.9% of Bio-Techne shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Agilent Technologies presently has a consensus target price of $146.15, suggesting a potential upside of 20.10%. Bio-Techne has a consensus target price of $81.25, suggesting a potential upside of 33.48%. Given Bio-Techne's stronger consensus rating and higher probable upside, analysts clearly believe Bio-Techne is more favorable than Agilent Technologies.
Agilent Technologies has a beta of 1.11, meaning that its share price is 11% more volatile than the S&P 500. Comparatively, Bio-Techne has a beta of 1.3, meaning that its share price is 30% more volatile than the S&P 500.
Agilent Technologies pays an annual dividend of $0.99 per share and has a dividend yield of 0.8%. Bio-Techne pays an annual dividend of $0.32 per share and has a dividend yield of 0.5%. Agilent Technologies pays out 22.8% of its earnings in the form of a dividend. Bio-Techne pays out 32.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Agilent Technologies is clearly the better dividend stock, given its higher yield and lower payout ratio.
In the previous week, Agilent Technologies had 31 more articles in the media than Bio-Techne. MarketBeat recorded 47 mentions for Agilent Technologies and 16 mentions for Bio-Techne. Bio-Techne's average media sentiment score of 1.01 beat Agilent Technologies' score of 0.96 indicating that Bio-Techne is being referred to more favorably in the news media.
Agilent Technologies has a net margin of 19.27% compared to Bio-Techne's net margin of 13.22%. Agilent Technologies' return on equity of 25.56% beat Bio-Techne's return on equity.
Summary
Agilent Technologies beats Bio-Techne on 12 of the 20 factors compared between the two stocks.
Get Bio-Techne News Delivered to You Automatically
Sign up to receive the latest news and ratings for TECH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Bio-Techne Competitors List
Related Companies and Tools
This page (NASDAQ:TECH) was last updated on 3/25/2025 by MarketBeat.com Staff
Buy TECH Stock Free TECH Stock Alerts